Page last updated: 2024-10-16

acetaldehyde and Lung Diseases, Interstitial

acetaldehyde has been researched along with Lung Diseases, Interstitial in 1 studies

Acetaldehyde: A colorless, flammable liquid used in the manufacture of acetic acid, perfumes, and flavors. It is also an intermediate in the metabolism of alcohol. It has a general narcotic action and also causes irritation of mucous membranes. Large doses may cause death from respiratory paralysis.
acetaldehyde : The aldehyde formed from acetic acid by reduction of the carboxy group. It is the most abundant carcinogen in tobacco smoke.
aldehyde : A compound RC(=O)H, in which a carbonyl group is bonded to one hydrogen atom and to one R group.
acetyl group : A group, formally derived from acetic acid by dehydroxylation, which is fundamental to the biochemistry of all forms of life. When bound to coenzyme A, it is central to the metabolism of carbohydrates and fats.

Lung Diseases, Interstitial: A diverse group of lung diseases that affect the lung parenchyma. They are characterized by an initial inflammation of PULMONARY ALVEOLI that extends to the interstitium and beyond leading to diffuse PULMONARY FIBROSIS. Interstitial lung diseases are classified by their etiology (known or unknown causes), and radiological-pathological features.

Research Excerpts

ExcerptRelevanceReference
"To compare serum anti-malondialdehyde-acetaldehyde (anti-MAA) antibody levels and MAA expression in lung tissue from patients with rheumatoid arthritis-associated interstitial lung disease (RA-ILD) to those found in controls."7.91Malondialdehyde-Acetaldehyde Adducts and Antibody Responses in Rheumatoid Arthritis-Associated Interstitial Lung Disease. ( Ascherman, DP; Caplan, L; Deane, KD; Demoruelle, MK; Duryee, MJ; England, BR; Klassen, LW; Mahajan, TD; Mikuls, TR; Poole, JA; Roul, P; Singh, N; Thiele, GM, 2019)
"To compare serum anti-malondialdehyde-acetaldehyde (anti-MAA) antibody levels and MAA expression in lung tissue from patients with rheumatoid arthritis-associated interstitial lung disease (RA-ILD) to those found in controls."3.91Malondialdehyde-Acetaldehyde Adducts and Antibody Responses in Rheumatoid Arthritis-Associated Interstitial Lung Disease. ( Ascherman, DP; Caplan, L; Deane, KD; Demoruelle, MK; Duryee, MJ; England, BR; Klassen, LW; Mahajan, TD; Mikuls, TR; Poole, JA; Roul, P; Singh, N; Thiele, GM, 2019)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
England, BR1
Duryee, MJ1
Roul, P1
Mahajan, TD1
Singh, N1
Poole, JA1
Ascherman, DP1
Caplan, L1
Demoruelle, MK1
Deane, KD1
Klassen, LW1
Thiele, GM1
Mikuls, TR1

Other Studies

1 other study available for acetaldehyde and Lung Diseases, Interstitial

ArticleYear
Malondialdehyde-Acetaldehyde Adducts and Antibody Responses in Rheumatoid Arthritis-Associated Interstitial Lung Disease.
    Arthritis & rheumatology (Hoboken, N.J.), 2019, Volume: 71, Issue:9

    Topics: Acetaldehyde; Aged; Antibody Formation; Arthritis, Rheumatoid; Autoantibodies; Autoantigens; Case-Co

2019